Received May 15, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | Z005055 | — |
No adverse effects were reported.; Physician called to report that an expired dose of GARDASIL 9 was administered to a patient on 3/11/2026; This spontaneous report was received from a physician and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies, or concomitant therapies was provided. On 11-Mar-2026, the patient was vaccinated with Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) 0.5 ml (route of administration and anatomical location not reported, lot number Z005055, which was verified to be valid, expiration date on 27-Feb-2026) for prophylaxis (Expired product administered). No adverse effects were reported.